Market Insights report
The Immunosuppressants market covers drugs which suppress the immune response. These remedies are used in different therapy areas, mainly to treat auto-immune diseases, such as psoriasis. Anti-rejection drugs administered after organ transplantations are also included in this market. Monoclonal antibodies are an important type of immunosuppressant.
What's included?
The Immunosuppressants market is characterized by high growth rates. Revenues are expected to more than double in the forecast period. This rise is mainly driven by innovative drugs used for the treatment of psoriasis and allergic diseases, among others. Due to the COVID-19 pandemic, patients avoided seeing doctors in certain periods in 2020 and 2021, resulting in postponed surgeries, fewer new patients, and a decrease in physician-administered treatments. These moderate negative effects are hardly reflected in the revenue curve because rising sales of the market-leading products have counteracted these trends.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)